Mr. James Van Staveren reports

GLOW ANNOUNCES CLOSING OF NON-BROKERED PRIVATE PLACEMENT

Glow Lifetech Corp., further to its news release of April 15, 2024, has completed a non-brokered private placement financing for gross proceeds of $605,000 through the issuance of 20,166,667 units in the capital of the company at a price of three cents per unit. Each unit comprised one common share in the capital of the company and one common share purchase warrant. Each warrant entitles the holder thereof to acquire one common share at a price of five cents per common share for a period of 18 months from the date of issuance. The company intends to use the gross proceeds from the offering for general working capital purposes.

All securities issued in connection with the offering are subject to a hold period of four months plus a day from the date of issuance and the resale rules of applicable securities legislation.

About Glow Lifetech Corp.

Glow Lifetech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption and effectiveness. Glow Lifetech has rights to the groundbreaking, plant-based MyCell Technology delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates that unlock the full healing potential of the valuable compounds.

We seek Safe Harbor.